Literature DB >> 20700050

A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis.

Garrick Chak1, James V Aquavella.   

Abstract

PURPOSE: To describe a technique for Nd:YAG laser photodiscission of retroprosthetic membrane (RPM) in keratoprosthesis patients that minimizes damage to the optic.
METHODS: Prospective review of Boston type I keratoprosthesis patients at 1 site who received Nd:YAG treatment for RPM from 2005 to 2009. Outcomes were based on slit-lamp examination of the optic immediately after YAG treatment, tactile intraocular pressure at follow-up, and complications from the outpatient procedure.
RESULTS: The incidence of RPM was 24.1% (39 of 162 eyes). Of 26 RPM eyes receiving YAG treatment, 18 had 1 YAG treatment, 6 had multiple YAG treatments, and 2 had surgical excision despite multiple YAG treatments because of membrane thickness. All 26 eyes had no intraoperative complications, no damage to the optic from slit-lamp examination, and soft tactile intraocular pressures.
CONCLUSION: Based on the office procedures from our patient base, YAG retroprosthetic membranectomy using a peripheral "can-opener" approach is effective and safe with no evident damage to the optic.

Entities:  

Mesh:

Year:  2010        PMID: 20700050     DOI: 10.1097/ICO.0b013e3181cda001

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Randomized controlled trial comparing Nd:YAG laser photocoagulation and bipolar electrocautery in the management of epistaxis.

Authors:  Jing Zhang; Luhong Cao; Chunsheng Wei
Journal:  Lasers Med Sci       Date:  2017-07-13       Impact factor: 3.161

3.  Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.

Authors:  Maria Stephanie R Jardeleza; Marc-Andre Rheaume; James Chodosh; Anne Marie Lane; Claes H Dohlman
Journal:  Digit J Ophthalmol       Date:  2015-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.